Parallel

Parallel has taken the least glamorous path into hospital AI, and that is the interesting thing about it. Most coding vendors ask a hospital to stand up custom EHR API integrations before any value shows up; Parallel instead connects through remote VPN access and Robotic Process Automation, driving the same systems a human coder already uses. For a hospital IT team with a long backlog of integration requests, that reframes the project from a software build to an access grant. Functionally, the coding agent does three things: it reads unstructured clinical documentation and patient context with generative AI models, applies coding standards plus hospital-specific rules, and then splits its output by case complexity. Simple inpatient and outpatient cases get automated coding; complex stays get smart suggestions that a human coder reviews and approves. That split is a deliberate design choice — the department keeps a review step, which is also why Parallel markets itself as working side by side with coding teams rather than replacing them. The commercial pitch is straightforward: work down case backlogs, add capacity during high-volume periods without hiring contract coders, and improve reimbursement accuracy by making coded diagnoses reflect documented medical activity. The 2026 releases are the substance of the current product. In September 2026 Parallel upgraded its AI engine, reporting ICD-10 coding accuracy roughly doubled and adding procedure coding alongside the original diagnosis coding. In October 2026 the Parallel assistant gained data analysis capability, which extends it past pure coding queries. Both are vendor-reported numbers, so the right move is to re-run them on your own case mix during a pilot rather than assume the gains transfer. The compliance posture is aimed squarely at European buyers: health data hosted in the EU with HDS-certified infrastructure providers in line with GDPR, hospital data not used to train the underlying models, and English plus French support. For a French or broader European hospital group, that combination is often the gate that decides whether a vendor gets a pilot at all. Where Parallel does not fit is equally clear. The connection method is the hard constraint — hospitals with restrictive IT policies that will not permit remote VPN or RPA access to clinical systems cannot use it, and no amount of accuracy improvement changes that. Small clinics with coding volume too low to justify a deployment are not the target. And anyone shopping for a general-purpose clinical AI assistant or chatbot is looking at the wrong category; coding is effectively the whole product today, with data analysis in the assistant as the first adjacent step. Our recommendation: treat Parallel as a focused point solution for hospital coding departments, and run the pilot on measured coder acceptance and coded-case accuracy. The $20M Series A signals staying power, but it is not the reason to buy. The reason to buy is that it